Author:
Bédard Annabelle,Basagaña Xavier,Anto Josep M.,Garcia-Aymerich Judith,Devillier Philippe,Arnavielhe Sylvie,Bedbrook Anna,Onorato Gabrielle L.,Czarlewski Wienczyslawa,Murray Ruth,Almeida Rute,Fonseca Joao,Costa Elisio,Malva Joao,Morais-Almeida Mario,Pereira Ana Margarida,Todo-Bom Ana,Menditto Enrica,Stellato Cristiana,Ventura Maria Teresa,Cruz Alvaro A.,Stelmach Rafaël,da Silva Jane,Larenas-Linnemann Désirée,Fuentes-Pérez José M.,Huerta-Villalobos Yunuen R.,Emuzyte Regina,Kvedariene Violeta,Valiulis Arunas,Kuna Piotr,Samolinski Boleslaw,Klimek Ludger,Mösges Ralph,Pfaar Oliver,Shamai Sara,Annesi-Maesano Isabelle,Bosse Isabelle,Demoly Pascal,Fontaine Jean-François,Cardona Vicky,Mullol Joaquim,Valero Antonio,Roller-Wirnsberger Regina E.,Tomazic Peter Valentin,Chavannes Niels H.,Fokkens Wytske J.,Reitsma Sietze,Bewick Mike,Ryan Dermot,Sheikh Aziz,Haahtela Tari,Toppila-Salmi Sanna,Valovirta Erkka,Makris Michael,Papadopoulos Nikos G.,Prokopakis Emmanuel P.,Psarros Fotis,Cingi Cemal,Gemicioğlu Bilun,Yorgancioglu Arzu,Bosnic-Anticevich Sinthia,O'Hehir Robyn E.,Bachert Claus,Hellings Peter W.,Pugin Benoit,Bindslev-Jensen Carsten,Eller Esben,Kull Ingrid,Melén Erik,Wickman Magnus,De Vries Gert,van Eerd Michiel,Agache Ioana,Ansotegui Ignacio J.,Dykewicz Mark S.,Casale Thomas,Wallace Dana,Waserman Susan,Laune Daniel,Bousquet Jean
Funder
North Portugal Regional Operational Programme
European Regional Development Fund
GlaxoSmithKline
Mundipharm
Novartis
Leti
Bial
AstraZeneca
Research Foundation
MSD
Chiesi
Boehringer Ingelheim
Sanofi
UCB
TEVA
ASIT biotech
Nuvo
Bayer
FAES
Johnson & Johnson
Meda
Optima
Ursapharm
BitopAG
Hulka
Bencard
Stallergenes
Lofarma
Roxall
Atmos
Bionorica
Otonomy
Ferrero
ALK-Abelló
Allergopharma
Stallergenes Greer
HAL Allergy Holding B.V.
HAL Allergie GmbH
Bencard Allergie GmbH
Allergy Therapeutics
Biomay
Circassia
Biomedical Systems
Roche
Erkko Foundation
Gerolymatos
Cipla
Hikma
Menarini
Mundipharma
Mylan
Sanofi-Aventis
Takeda
Teva
Uriach
Subject
Immunology,Immunology and Allergy